Clinical Potential of Growth Hormone in the Treatment of Congestive Heart Failure

被引：0
|
作者：
Jörgen Isgaard
Claes-Håkan Bergh
机构：
[1] Sahlgrenska University Hospital,Research Center for Endocrinology and Metabolism
[2] Sahlgrenska University Hospital,Division of Cardiology
来源：
BioDrugs | 1999年 / 12卷
关键词：
Growth Hormone; Adis International Limited; Dilate Cardiomyopathy; Growth Hormone Receptor; Idiopathic Dilate Cardiomyopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Substantial evidence supports a role for the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis in regulation of normal cardiac growth, structure and function. Moreover, experimental data suggest beneficial effects of GH and IGF-1 on contractility and peripheral resistance in rats with impaired cardiac function. An increased Ca++ responsiveness is one possible underlying cause for the improvement in contractility, although effects of GH and IGF-1 on apoptosis may also play a more long term role for cardiomyocyte survival.
引用
收藏
页码：245 / 250
页数：5
相关论文
共 50 条
  • [41] Growth hormone treatment of children with human immunodeficiency virus-associated growth failure
    Pinto, G
    Blanche, S
    Thiriet, I
    Souberbielle, JC
    Goulet, O
    Brauner, R
    EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (12) : 937 - 938
  • [42] Recombinant human growth hormone treatment in infants with chronic renal failure
    Maxwell, H
    Rees, L
    ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (01) : 40 - 43
  • [43] Growth hormone treatment of idiopathic short stature: Clinical studies
    Hintz, RL
    GROWTH HORMONE & IGF RESEARCH, 2005, 15 : S6 - S8
  • [44] New findings on brain actions of growth hormone and potential clinical implications
    Donato Jr, Jose
    Kopchick, John J.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (03) : 541 - 553
  • [45] Hormone replacement therapy in heart failure
    Arcopinto, Michele
    Salzano, Andrea
    Isgaard, Jorgen
    Cittadini, Antonio
    CURRENT OPINION IN CARDIOLOGY, 2015, 30 (03) : 277 - 284
  • [46] Clinical Characteristics of Children with Combined Pituitary Hormone Deficiency and the Effects of Growth Hormone Treatment
    Besci, Ozge
    Sevim, Reyhan Deveci
    Acinikli, Kubra Yuksek
    Demir, Korcan
    Catli, Gonul
    Ozhan, Bayram
    Unuvar, Tolga
    Anik, Ahmet
    Abaci, Ayhan
    Altincik, Ayca
    KLINISCHE PADIATRIE, 2025, 237 (01): : 11 - 20
  • [47] Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models
    Wit, J. M.
    Ranke, M. B.
    Albertsson-Wikland, K.
    Carrascosa, A.
    Rosenfeld, R. G.
    Van Buuren, S.
    Kristrom, B.
    Schoenau, E.
    Audi, L.
    Hokken-Koelega, A. C. S.
    Bang, P.
    Jung, H.
    Blum, W. F.
    Silverman, L. A.
    Cohen, P.
    Cianfarani, S.
    Deal, C.
    Clayton, P. E.
    de Graaff, L.
    Dahlgren, J.
    Kleintjens, J.
    Roelants, M.
    HORMONE RESEARCH IN PAEDIATRICS, 2013, 79 (05): : 257 - 270
  • [48] Evaluation of clinical and laboratory parameters during 2 years of growth hormone treatment in prepubertal children with chronic renal failure
    Simon, D
    Noel, M
    Brun, P
    Porquet, D
    Rocchicioli, P
    Loirat, C
    Czernichow, P
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (08) : 688 - 694
  • [49] Effects of β-Blockers on Neurohormonal Activation in Patients with Congestive Heart Failure
    David Baran
    Evelyn M. Horn
    Katarzyna Hryniewicz
    Stuart D. Katz
    Drugs, 2000, 60 : 997 - 1016
  • [50] RECRUITING PATIENTS TO CLINICAL-TRIALS - LESSONS FROM STUDIES OF GROWTH-HORMONE TREATMENT IN RENAL-FAILURE
    POSTLETHWAITE, RJ
    REYNOLDS, JM
    WOOD, AJ
    EVANS, JHC
    LEWIS, MA
    EMINSON, DM
    ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (01) : 30 - 35
12345